An Open Label, Randomized, Four-period, Two-sequence, Fully Replicated, Single-dose, Crossover Study of the Relative Bioavailability of Two Formulations of Extended-release Divalproex Sodium Tablets in Fed Patients With Stable Epilepsy.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- 23 Jul 2013 New trial record